Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria “is more widespread in Southeast Asia than previously reported,” Science News/Wired Science reports.
Kaiser Family Foundation Looks AtÂ Views On The U.S. Role In Global Health As a follow-up to a survey conducted in May 2009, this poll examines Americans’ attitudes toward U.S. global health investments and priorities. Some key findings include: the majority of Americans support maintaining (32%) or increasing (34%) spending on…
TIME reports on evidence along the Thai-Cambodia border that the malaria parasite is gaining resistance to artemisinin â€“ “the only remaining effective drug in the world’s arsenal against malaria’s most deadly strain.”
In a session at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, experts discussed the tools required to eradicate the disease and highlighted insecticide and drug resistance in some parts of the world, Xinhua reports.
On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. “Key among the strategies … is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. … RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative,” the news service writes (11/3).
Also In Global Health News: U.S. Grant To Uganda; Reproductive Health In Philippines; Counterfeit Drugs
U.S. Grants Uganda $246M In Aid To Improve Agricultural, Health Systems The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda’s agricultural and health systems, Reuters reports. “More than $170 million will be spent on health and education to combat the HIV/AIDS…
CNN examines a recent report by researchers that warns of increasing antibiotic resistance and appeals for governments to take action to develop new antibiotics to avert a health crisis.
Also In Global Health News: News Outlets Explore AIDS Vaccine Research; Chloroquine Resistance Unraveled; Authorities Contest Maternal Mortality Report
News Outlets Focus On Participants In AIDS Vaccine Study, Potential Impact Of AIDS Vaccine The Associated Press examines the role of the Thai participants in the recent clinical trial of an experimental HIV vaccine which showed modest potential for preventing infection. “Nearly 16,000 Thais ignored the false rumors that they…
WHO Asia-Pacific Countries Pledge To Use Artemisinin With Other Drugs By 2015 To Prevent Drug-Resistance
On Wednesday, nine of the 10 countries in the WHO’s Asia-Pacific region “that suffer most” from malaria pledged to phase out the use of artemisinin-only to treat malaria and use it in combination with other drugs by 2015, Reuters reports (Lyn, 9/23).
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers — CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune — had won FDA approval, paving the way for a U.S. large-scale vaccination campaign, the Wall Street Journal reports. The application for GlaxoSmithKline PLC’s vaccine is still being considered.